Ruizhi Wang

1.3k citations
62 papers · 1.0k indexed · h-index 17
Topics
Nanoplatforms for cancer theranostics (9 papers)Nanoparticle-Based Drug Delivery (9 papers)MicroRNA in disease regulation (4 papers)

In The Last Decade

Ruizhi Wang

60 papers receiving 997 citations

Peers

Ruizhi Wang
Comparison fields: 5 of 112
  • Biomedical Engineering 395
  • Molecular Biology 320
  • Materials Chemistry 229
  • Biomaterials 210
  • Oncology 82
Replace Xinyue Chen with:
Xinyue Chen China
Mingfeng Ge China
Xiaoqi Zhu China
Sang Kyoon Kim South Korea
Gang Huang China
Heng Guo China
Jan Balvan Czechia
Nicolas Szita United Kingdom
Jianhua Song China
Ruizhi Wang relative to Xinyue Chen China Xinyue Chen's profile →
Citations per field
00.5×
Xinyue Chen · 1×
Citations per year

Countries citing papers authored by Ruizhi Wang

Since Specialization
Citations

This map shows the geographic impact of Ruizhi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruizhi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruizhi Wang more than expected).

Fields of papers citing papers by Ruizhi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruizhi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruizhi Wang. The network helps show where Ruizhi Wang may publish in the future.

Co-authorship network of co-authors of Ruizhi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruizhi Wang. A scholar is included among the top collaborators of Ruizhi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruizhi Wang. Ruizhi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 7
3 7
4
Motion Analysis of a Moored Semi-submersible Floating Offshore Wind Turbine in Focused Waves by a Consistent Second-order Hydrodynamic Model
1
5 3
6 5
7 2
8 15
9 10
10 5
11 16
12 9
13 31
14 27
15 9
16 13
17 12
18 6
19
Crisis control of swollen bag problem of soybean paste
1
20 35

About Ruizhi Wang

Ruizhi Wang is a scholar working on Biomaterials, Hepatology and Cancer Research, having authored 62 papers that have together received 1.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (9 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Biomaterials (210 citations), Biomedical Engineering (395 citations) and Media Technology (57 citations). Ruizhi Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiangyang Shi, Yong Hu, Yu Luo, Xiaolin Wang, Mingwu Shen, Xin Li, Jingchao Li, Kai Zhu, Haitao Sun and Siyu Chen. Their work appears in journals such as Nano Letters, Scientific Reports and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026